Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy »

Stanford Health Care

Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system. Head & neck Ho, A. S., Luu, M., Balzer, B. L., Aro, K., Jang, J. K., Mita, A. C., Scher, K. S., Mallen-St Clair, J., Vasquez, M., Bastien, A. J., Epstein, J. B., Lin, D., Chen, M. M., Zumsteg, Z. S. 2023

Abstract

BACKGROUND: The comparative impact of histologic variants and grade has not been well described.METHODS: Salivary cancer histologies were profiled using hospital and population-based cancer registries. Multivariable models were employed to assess relationships between histology, grade, and survival.RESULTS: On univariate analysis, histologic variants exhibited a wide spectrum of mortality risk (5-year overall survival (OS): 86% (acinic cell carcinoma), 78% (mucoepidermoid carcinoma), 72% (adenoid cystic carcinoma), 64% (carcinoma ex-pleomorphic adenoma), 52% (adenocarcinoma NOS), and 47% (salivary duct carcinoma) (p<0.001). However, on multivariable analysis these differences largely vanished. Worsening grade corresponded with deteriorating survival (5-year OS: 89% [low-grade], 81% [intermediate-grade], 45% [high-grade]; p<0.001), which was upheld on multivariable analysis and propensity score matching. Recursive partitioning analysis generated TNM+G schema (c-index 0.75) superior to the existing system (c-index 0.73).CONCLUSION: Grade represents a primary determinant of salivary cancer prognosis. Integrating grade into stage strengthens current staging systems.

View details for DOI 10.1002/hed.27429

View details for PubMedID 37345665